Overview
Megasphaera elsdenii is a strictly anaerobic, Gram-negative bacterium belonging to the family Veillonellaceae within the phylum Firmicutes. Despite being classified within the traditionally Gram-positive Firmicutes, it is one of the unusual Gram-negative members of this phylum. M. elsdenii is primarily known as a dominant ruminant gut organism where it plays a critical role in preventing ruminal acidosis by converting lactate to short-chain fatty acids. While it is sparsely present in the human gut, its lactate-to-butyrate conversion capacity has generated interest in potential human health applications.
Classification
M. elsdenii belongs to the genus Megasphaera within the Veillonellaceae family, order Veillonellales. It shares its family with other Gram-negative Firmicutes including Dialister invisus and Veillonella parvula. The species was first isolated from sheep rumen in 1953 and has since become one of the best-characterized ruminant gut bacteria, with the commercial probiotic product Lactipro (strain LC1) widely used in cattle management.
Key Characteristics
M. elsdenii is distinguished by its ability to rapidly metabolize lactate, converting it to butyrate, propionate, and valerate. This lactate utilization capacity is its primary ecological role, preventing the dangerous accumulation of lactic acid that causes ruminal acidosis in cattle. The bacterium can metabolize both lactate and glucose as carbon sources under strictly anaerobic conditions. In human gut fermentation studies, M. elsdenii co-presence has been associated with increased butyrate production but also significantly increased gas production, which may present a concern for individuals with irritable bowel syndrome or gas-related discomfort.
Health Significance
The human health significance of M. elsdenii remains uncertain due to its low native abundance in the human gut. While its capacity to convert lactate to butyrate could theoretically benefit colonocyte health and help manage lactate accumulation conditions, its primary ecological role is firmly established in ruminant systems. Research suggests that its presence in human gut fermentation may increase intestinal gas production, limiting its potential as a human probiotic without careful dose and formulation optimization. The species is included in some microbiome testing panels as a minority community member, and its detection may reflect dietary or environmental exposures. Further research is needed to determine whether targeted supplementation could provide meaningful benefits for human metabolic health without undesirable gastrointestinal side effects.